Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Quanterix CorporationNASDAQ: QTRX

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 46.98M shares rose 21.3% year over year, ahead of the +16.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +4.9% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +21.3% holds above the trailing-twelve-month pace of +16.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
46.98M+0.4% QoQ
Last fiscal yearDec 2025
42.64M+11.1% YoY
LTMMar 2026
44.68M+16.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+21.3%——
1 year+11.1%——
3-year CAGR+4.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
42.64M USD
Year-over-year change
+11.1%
4-year CAGR
+4.3%

Weighted Avg Shares (Diluted) vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's LTM Mar 2026 weighted avg shares (diluted) of 44.68M shares is the 3rd highest of the 11 companies compared; the peer median is 38.74M shares.
  • Its year-over-year change of +16.0% is the 5th highest of 11, against a peer median of +12.5%.
  • Over three fiscal years its annual growth of +4.9% compares with a peer median of +7.9%.
QTRX Competitors Peer median
Weighted Avg Shares (Diluted) for QTRX and competitors
Company Period LTM YoY 3-year CAGR
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
IMRXImmuneering CorporationLTM Mar 202640.92M +29.8%+18.6%
SENSSenseonics Holdings, Inc.LTM Mar 202640.57M +23.7%+10.5%
VMDViemed Healthcare, Inc.LTM Mar 202640.56M -1.4%+0.8%
MASS908 Devices Inc.LTM Mar 202636.93M +6.4%+7.3%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
Peer median (excluding QTRX) 38.74M+12.5%+7.9%

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue110.56M105.52M121.14M135.44M138.65M
Cost of Revenue45.78M60.16M48.14M54.32M73.94M
Gross Profit64.77M45.36M73M81.12M64.72M
Gross Margin58.6%43.0%60.3%59.9%46.7%
Research & Development28.38M26.81M26.06M31.08M35.92M
Selling, General & Admin92.91M91.85M92.82M104.64M138.85M
Operating Expenses121.29M149.63M118.99M133.74M174.53M
Depreciation & Amortization4.88M5.41M8.29M8.36M18.93M
EBITDA(50.3M)(67.89M)(36.37M)(29.74M)(93.35M)
EBITDA Margin-45.5%-64.3%-30.0%-22.0%-67.3%
Operating Income(56.52M)(104.26M)(45.99M)(52.62M)(109.82M)
Operating Margin-51.1%-98.8%-38.0%-38.8%-79.2%
Interest Income05.13M15.84M14.66M8.57M
Interest Expense403K0000
Other Income / Expenses937K4.85M18.36M14.52M(2.46M)
Income Before Tax(55.58M)(99.41M)(27.64M)(38.1M)(112.27M)
Pre-Tax Margin-50.3%-94.2%-22.8%-28.1%-81.0%
Income Tax Expense(36K)164K719K434K(5.12M)
Net Income(55.55M)(99.57M)(28.35M)(38.53M)(107.15M)
Net Margin-50.2%-94.4%-23.4%-28.4%-77.3%
EPS (Basic)(1.60)(2.61)(0.86)(1.00)(2.51)
EPS (Diluted)(1.60)(2.61)(0.86)(1.00)(2.51)
Weighted Avg Shares36M36.99M37.59M38.37M42.64M
Weighted Avg Shares (Diluted)36M36.99M37.59M38.37M42.64M

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.